Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 12,524 | 14,034 | 13,434 | 17,855 | 18,294 |
| Operating Income | -12,524 | -14,034 | -13,434 | -17,855 | -18,294 |
| Interest Expense | 1,276 | 1,294 | 1,296 | 1,316 | 1,266 |
| Other Income | 439 | 549 | 675 | 839 | 896 |
| Pre-tax Income | -13,361 | -14,779 | -14,055 | -18,332 | -18,664 |
| Net Income Continuous | -13,361 | -14,779 | -14,055 | -18,332 | -18,664 |
| Minority Interests | -6,556 | -7,296 | -6,957 | -9,135 | -9,361 |
| Net Income | $-6,805 | $-7,483 | $-7,098 | $-9,197 | $-9,303 |
| EPS Basic Total Ops | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 |
| EPS Basic Continuous Ops | -0.51 | -0.57 | -0.54 | -0.72 | -0.74 |
| EPS Diluted Total Ops | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 |
| EPS Diluted Continuous Ops | -0.51 | -0.57 | -0.54 | -0.72 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.29 | -0.27 | N/A | N/A |
| EBITDA(a) | $-12,501 | $-14,068 | $-13,614 | $-18,188 | $-18,590 |